Alzheimer’s Disease is the largest neurodegenerative disease opportunity, affecting over 5.4 million sufferers, 15 million unpaid caregivers and costing over $200 billion annually in the United States alone. Currently, there are no effective treatments for Alzheimer’s Disease on the market.
Alzheimer’s has an enormous social and economic burden.
Alzheimer’s is the most expensive condition in the US, costing over $200 billion in direct costs annually. This is expected to increase to $1.2 trillion by 2050. There are more than 15.6 million unpaid caregivers in the US alone, representing more than $200 billion additional dollars of social burden.